| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |